uk-plab-1 MCQ (SBA): Type 2 diabetes – second-line therapy

Instant feedback + full explanation. One question, done properly.

ModerateEndocrinologyType 2 diabetes – second-line therapyuk-plab-1

A 64-year-old man with type 2 diabetes on maximum tolerated Metformin has HbA1c 75 mmol/mol. He has established cardiovascular disease and an eGFR of 58 mL/min/1.73 m². According to NICE, which additional agent would be most appropriate to add?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.

uk-plab-1 MCQ: Type 2 diabetes – second-line therapy — Answer & Explan